Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. TSLA
4. TXN
5. GOOG
6. IBM
7. LVS
8. INTC
9. RJF
10. KNX

Go back to Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
(NASDAQ: ERNA) Delayed: 4.45 --0 (-0%)
Previous Close $4.45    52 Week High $ 
Open $4.45    52 Week Low $ 
Day High $4.45    P/E N/A 
Day Low $4.45    EPS $ 
Volume 3,021       

(NASDAQ: ERNA) Delayed: 4.45 --0 (-0%)
Previous Close $4.45    52 Week High $ 
Open $4.45    52 Week Low $ 
Day High $4.45    P/E N/A 
Day Low $4.45    EPS $ 
Volume 3,021